Merck is seeking ways to prepare for a significant upcoming patent cliff. The company has just announced another acquisition ...

The death of a third patient tied to a Sarepta Therapeutics gene therapy this year sent the company’s shares nosediving 36% Friday, halting the momentum the stock generated just a day earlier after ...

For $10 billion, Merck is acquiring a promising healthcare company which is in the early stages of its growth. Key to its ...

Merck is making big pharma waves again with a $10 billion deal to acquire Verona Pharma, reports Colin Kellaher for the Wall ...

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

Michelle Xia gained experience at U.S. pharmaceutical firms before launching her own biotech company back home in China. In a ...

Backed by an initial funding of $15 million from the National Science Foundation, the Regenerative Medicine Engine is the ...

Three young Triangle-based medical technology companies with roots in Duke University research labs are getting major global attention from their industry. They’re among the 65 cutting-edge companies ...

William Blair analysts cut AbbVie’s FY2025 earnings estimate to $11.82 per share from $12.21, citing revised outlooks. Other ...

Bristol Myers SquibbBMY announced a strategic collaboration agreement with BioNTechBNTX for the global co-development and co-commercialization of the latter’s investigational bispecific antibody ...

As global corporations deepen their roots in MENA, the region continues to evolve into a magnet for investment, innovation, and cross-border collaboration. From aerospace to AI, healthcare to ...